年轻患者Koos IV级前庭神经鞘瘤的立体定向放射外科治疗:一项多机构研究
这项回顾性多中心分析纳入176例≤45岁、因Koos IV级前庭神经鞘瘤出现非危及生命或致残症状且随访≥12个月的患者,接受单次立体定向放射外科治疗。5年和10年无进展生存率分别为90.9%和86.7%,可服务听力保留概率分别为56.8%和45.2%,面神经功能改善或保留概率5年和10年均为95.7%。作者认为单次立体定向放射外科是特定年轻患者手术切除的安全有效替代方案,需更长期随访。
要点
- 5年和10年无进展生存率分别为90.9%和86.7%。
- 5年和10年可服务听力保留概率分别为56.8%和45.2%。
- 面神经功能改善或保留概率5年和10年均为95.7%。
核心结论
- 单次立体定向放射外科是特定≤45岁Koos IV级前庭神经鞘瘤患者手术切除的安全有效替代方案,尤其适用于有内科合并症和拒绝手术者。
- 需更长期随访。
研究设计与样本
- 回顾性多中心分析,纳入接受单次立体定向放射外科治疗、≤45岁、因Koos IV级前庭神经鞘瘤出现非危及生命或致残症状且随访≥12个月的患者。
- 共纳入176例患者,中位年龄36.0岁(IQR 9),中位肿瘤体积9.3 cm³(IQR 4.7)。
- 中位处方剂量12 Gy(IQR 0.5),中位随访37.5个月(IQR 53.5)。
主要发现
- 5年和10年无进展生存率分别为90.9%和86.7%。
- 早期肿瘤增大发生于10.9%的病例,并与末次随访时的肿瘤进展相关。
- 5年和10年可服务听力保留概率分别为56.8%和45.2%。
- 面神经功能改善或保留概率5年和10年均为95.7%。
- 放射性不良反应发生率为19.9%,新发脑积水发生率为4.0%。
临床怎么用
- 作者认为单次立体定向放射外科是特定≤45岁Koos IV级前庭神经鞘瘤患者手术切除的安全有效替代方案,尤其适用于有内科合并症和拒绝手术者。
局限性
- 需更长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Surgery is the treatment of choice for large vestibular schwannomas (VS). Stereotactic radiosurgery (SRS) has been suggested as an alternative to resection in selected patients. However, the safety and efficacy of SRS in Koos grade IV patients ≤ 45 years old has not been evaluated. The aim of this study is to describe the clinical and radiological outcomes of Koos grade IV in young patient managed with a single-session SRS. METHODS: This retrospective, multicenter analysis included SRS-treated patients, ≤ 45 years old presenting with non-life threatening or incapacitating symptoms due to a Koos Grade IV VS and with follow-up ≥ 12 months. Tumor control and neurological outcomes were evaluated. RESULTS: 176 patients [median age of 36.0 (IQR 9) and median tumor volume of 9.3 cm3 (IQR 4.7)] were included. The median prescription dose was 12 Gy (IQR 0.5). Median follow-up period was 37.5 (IQR 53.5) months. The 5- and 10-year progression-free survival was 90.9% and 86.7%. Early tumor enlargement occurred in 10.9% of cases and was associated with tumor progression at the last follow-up. The probability of serviceable hearing preservation at 5- and 10-years was 56.8% and 45.2%, respectively. The probability of improvement or preservation of facial nerve function was 95.7% at 5 and 10-years. Adverse radiation effects were noted in 19.9%. New-onset hydrocephalus occurred in 4.0%. CONCLUSION: Single-session SRS is a safe and effective alternative to surgical resection in selected patients ≤ 45 years old particularly those with medical co-morbidities and those who decline resection. Longer term follow up is warranted.
引用
- Dumot C, Pikis S, Mantziaris G, et al. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study. J Neurooncol. 2022. PMID: 36166113. doi:10.1007/s11060-022-04134-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。